Alzheimer’s disease: risk factors and potentially protective measures DOI Creative Commons
Marcos Vinícius Ferreira Silva,

Cristina de Mello Gomide Loures,

Luan Carlos Vieira Alves

et al.

Journal of Biomedical Science, Journal Year: 2019, Volume and Issue: 26(1)

Published: May 9, 2019

Alzheimer’s disease (AD) is the most common type of dementia and typically manifests through a progressive loss episodic memory cognitive function, subsequently causing language visuospatial skills deficiencies, which are often accompanied by behavioral disorders such as apathy, aggressiveness depression. The presence extracellular plaques insoluble β-amyloid peptide (Aβ) neurofibrillary tangles (NFT) containing hyperphosphorylated tau protein (P-tau) in neuronal cytoplasm remarkable pathophysiological cause patients’ brains. Approximately 70% risk developing AD can be attributed to genetics. However, acquired factors cerebrovascular diseases, diabetes, hypertension, obesity dyslipidemia increase development. aim present minireview was summarize mechanism main for AD. As complement, some protective associated with lower incidence, reserve, physical activity diet will also addressed.

Language: Английский

Neuroinflammation in Alzheimer's disease DOI
Michael T. Heneka, Monica J. Carson, Joseph El Khoury

et al.

The Lancet Neurology, Journal Year: 2015, Volume and Issue: 14(4), P. 388 - 405

Published: March 16, 2015

Language: Английский

Citations

4959

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders DOI
Melanie D. Sweeney, Abhay P. Sagare, Berislav V. Zloković

et al.

Nature Reviews Neurology, Journal Year: 2018, Volume and Issue: 14(3), P. 133 - 150

Published: Jan. 29, 2018

Language: Английский

Citations

2279

Development, maintenance and disruption of the blood-brain barrier DOI
Birgit Obermeier, Richard Daneman, Richard M. Ransohoff

et al.

Nature Medicine, Journal Year: 2013, Volume and Issue: 19(12), P. 1584 - 1596

Published: Dec. 1, 2013

Language: Английский

Citations

2076

A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules DOI Open Access
Aleksanteri Aspelund, Salli Antila, Steven T. Proulx

et al.

The Journal of Experimental Medicine, Journal Year: 2015, Volume and Issue: 212(7), P. 991 - 999

Published: June 15, 2015

The central nervous system (CNS) is considered an organ devoid of lymphatic vasculature. Yet, part the cerebrospinal fluid (CSF) drains into cervical lymph nodes (LNs). mechanism CSF entry LNs has been unclear. Here we report surprising finding a vessel network in dura mater mouse brain. We show that dural vessels absorb from adjacent subarachnoid space and brain interstitial (ISF) via glymphatic system. Dural transport deep (dcLNs) foramina at base skull. In transgenic model expressing VEGF-C/D trap displaying complete aplasia vessels, macromolecule clearance was attenuated dcLNs abrogated. Surprisingly, ISF pressure water content were unaffected. Overall, these findings indicate flow directly network, which may be important for macromolecules Importantly, results call reexamination role CNS physiology disease.

Language: Английский

Citations

1802

Blood-Brain Barrier Breakdown in the Aging Human Hippocampus DOI Creative Commons
Axel Montagne, Samuel Barnes, Melanie D. Sweeney

et al.

Neuron, Journal Year: 2015, Volume and Issue: 85(2), P. 296 - 302

Published: Jan. 1, 2015

Language: Английский

Citations

1720

Blood-Brain Barrier: From Physiology to Disease and Back DOI Open Access
Melanie D. Sweeney, Zhen Zhao, Axel Montagne

et al.

Physiological Reviews, Journal Year: 2018, Volume and Issue: 99(1), P. 21 - 78

Published: Oct. 3, 2018

The blood-brain barrier (BBB) prevents neurotoxic plasma components, blood cells, and pathogens from entering the brain. At same time, BBB regulates transport of molecules into out central nervous system (CNS), which maintains tightly controlled chemical composition neuronal milieu that is required for proper functioning. In this review, we first examine molecular cellular mechanisms underlying establishment BBB. Then, focus on physiology, endothelial pericyte transporters, perivascular paravascular transport. Next, discuss rare human monogenic neurological disorders with primary genetic defect in BBB-associated cells demonstrating link between breakdown neurodegeneration. review effects genes inheritance and/or increased susceptibility Alzheimer's disease (AD), Parkinson's (PD), Huntington's disease, amyotrophic lateral sclerosis (ALS) relation to other pathologies deficits. We next how dysfunction relates deficits majority sporadic AD, PD, ALS cases, multiple sclerosis, neurodegenerative disorders, acute CNS such as stroke, traumatic brain injury, spinal cord epilepsy. Lastly, BBB-based therapeutic opportunities. conclude lessons learned future directions, emphasis technological advances investigate functions living brain, at level, address key unanswered questions.

Language: Английский

Citations

1653

The Glymphatic System: A Beginner’s Guide DOI
Nadia Aalling,

Anne Sofie Finmann Munk,

Iben Lundgaard

et al.

Neurochemical Research, Journal Year: 2015, Volume and Issue: 40(12), P. 2583 - 2599

Published: May 6, 2015

Language: Английский

Citations

1629

The Cellular Phase of Alzheimer’s Disease DOI Creative Commons
Bart De Strooper, Eric Karran

Cell, Journal Year: 2016, Volume and Issue: 164(4), P. 603 - 615

Published: Feb. 1, 2016

Language: Английский

Citations

1573

Ageing as a Risk Factor for Disease DOI Creative Commons
Teresa Niccoli, Linda Partridge

Current Biology, Journal Year: 2012, Volume and Issue: 22(17), P. R741 - R752

Published: Sept. 1, 2012

Language: Английский

Citations

1550

The Pathobiology of Vascular Dementia DOI Creative Commons
Costantino Iadecola

Neuron, Journal Year: 2013, Volume and Issue: 80(4), P. 844 - 866

Published: Nov. 1, 2013

Language: Английский

Citations

1540